Panic Disorder
What is panic disorder? Panic disorder occurs when you experience recurring unexpected panic attacks. The DSM-5 defines panic attacks as abrupt surges of intense fear or discomfort that peak within minutes. People with the disorder live in fear of having a panic attack.
Cluster Number:
Wiki Number: PW150
Diagnosis: Panic Disorder
US Patients: 2.5% sometime in life
World Patients:
Sex Ratio: M;W2
Age Onset: adolescence or early adulthood
Brain Area: amygdala, anterior cingulate cortex, hippocampus and periaqueductal grey may all be autonomically stimulated and frightening extent
Symptoms: 1-5 or up to 20 minute duration; rapid heartbeat, dizziness, fear of losing control, going crazy or dying; choking, paralysis and others.
Progression: Treatment helps 50%, but 30% have recurrences.
Causes: PTSD, taking on too much responsibility, genetic, substance abuse-drug or alcohol;
Medications: Antidepressants, benzodiazopines, beta blockers
Therapies: learning positive self-talk helps to reduce the panic; reductions can occur within twelve weeks.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Internet-Delivered Versus Face-to-Face Cognitive Behavior Therapy for Anxiety Disorders: Systematic Review and Meta-Analysisby Narges Esfandiari on January 24, 2022
CONCLUSIONS: ICBT and face-to-face CBT created equivalent overall effects. in treatment of anxiety disorders. Since there have been similar systematic reviews about anxiety disorders so far, and in majority of them, ICBT has not been compared against face-to-face treatment. More research is needed to establish the general equivalence of the two treatment formats. Also, understanding what makes ICBT work is a challenge for future research.
- Psychosocial treatment for panic disorder: An umbrella review of systematic reviews and meta-analysesby Ana Rabasco on January 22, 2022
CONCLUSIONS: Future reviews should focus on improving their methodological quality. Although the included reviews supported CBT as an efficacious treatment for reducing panic symptoms among adults, future research could focus on how CBT compares to other psychosocial treatments and the efficacy of CBT for PD among other populations (e.g., children and adolescents) and among diverse cultural groups.
- COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers-a reviewby Ebrahim Payberah on January 21, 2022
CONCLUSION: Existing literature on the rates of vaccine hesitancy among people with mental health illness is limited. The mental health illness may increase the risk of hesitancy especially in patients having certain emotional disorders such as anxiety and phobia. More studies addressing vaccine hesitancy rates and factors associated with the mentally ill population need to be done in the future.
- Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trialsby Natasha Chawla on January 20, 2022
CONCLUSION: The findings suggest that SSRIs provide high rates of remission with low risk of adverse events for the treatment of panic disorder. Among SSRIs, sertraline and escitalopram were associated with high remission and low risk of adverse events. The findings were, however, based on studies of moderate to very low certainty levels of evidence, mostly as a result of within study bias, inconsistency, and imprecision of the findings reported.